Clinical Trial Update: DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC

View source ↗

Summary

The DREAM Study is a clinical trial evaluating DNA/RNA next-generation sequencing co-testing for driver-negative, treatment-resistant non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Baohui Han | Conditions: Non-Small Cell Lung Cancer | Status: RECRUITING